SCHEMBL16468424

SCHEMBL16468424

[2H]OC(=O)c1cc(C)c(=O)n(C)c1

nearest known ligand 0.46

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 20/20 0.46
BRD9 Q9H8M2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL480606 0.87 BRD4 (0.50) BRD4BRD9
SCHEMBL16486285 0.78 BRD4 (0.49) BRD4BRD9
SCHEMBL20726642 0.78 BRD4 (0.66) BRD4BRD9
SCHEMBL16486199 0.75 BRD4 (0.46) BRD4BRD9
SCHEMBL28132860 0.70 BRD4 (0.42) BRD4BRD9
SCHEMBL19869661 0.68 BRD4 (0.75) BRD4BRD9
SCHEMBL16468899 0.68 BRD4 (0.40) BRD4BRD9
SCHEMBL12659550 0.68 BRD4 (0.53) BRD4BRD9
SCHEMBL12157418 0.67 BRD4 (0.48) BRD4BRD9
SCHEMBL2260637 0.67 TTR (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3033335-B1 PYRIDINONES BOEHRINGER INGELHEIM INT (DE) 2020-04-15 EP disclosed
US-9296748-B2 Pyridinones BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2016-03-29 US disclosed
US-20150246919-A1 PYRIDINONES BOEHRINGER INGELHEIM INT (DE) 2015-09-03 US disclosed
US-20150051208-A1 PYRIDINONES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150051208-A1 PYRIDINONES MKI67, XDH, CDK6 BRD4 1346/4885BRD9 3868/4885
US-20150246919-A1 PYRIDINONES MKI67, XDH, CDK6 BRD4 1346/4885BRD9 3868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.